At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
Pivot Bridgedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Study for Evaluation of Acute Phase Safety and Efficacy of 'Pivot Bridge' to Short-term Treat Functional Tricuspid Regurgitation : Multi-center, Open Label, Single Arm, Investigator Initiated Exploratory Pilot Study
In Brief
A clinical study evaluating Pivot Bridge for Functional Tricuspid Regurgitation. Completed, enrolled 15 participants across 10 sites.
Detailed Summary
evaluation of safety and efficacy of 'Pivot Bridge' to short-term treat Functional Tricuspid regurgitation
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFunctional Tricuspid Regurgitation
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartMar 2023
First PostedMay 2023
Primary CompletionOct 2023
Study CompletionDec 2023
TodayJul 2026
First PostedMay 11, 2023
Enrollment StartMar 13, 2023
Primary CompletionOct 17, 2023
Study CompletionDec 27, 2023
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 3.1 years ago
Interventions
Pivot Bridgedevice
transcatheter for short-term treat Functional Tricuspid regurgitation